A brief history of pneumococcal vaccines.

作者: Robert Austrian

DOI: 10.2165/00002512-199915001-00001

关键词: PopulationAntibodyPenicillinIncidence (epidemiology)VirologyStreptococcus pneumoniaePharmacotherapyMedicineBacterial polysaccharideVaccinationImmunology

摘要: Attempts to control pneumococcal infection by vaccination, undertaken initially in 1911, have gone through 3 phases during the subsequent 8 decades. Initially, vaccines of killed cells prepared a variety ways were used epidemic settings with inconclusive results, although administered approximately 1 million recipients. The discovery that adults injected small amounts purified capsular polysaccharide developed antibodies homologous type led trial tetravalent vaccine showed conclusively its ability prevent types represented it. With advent penicillin and other effective antipneumococcal drugs, interest prophylaxis waned. Interest vaccination was revived only after demonstration some segments population remained at high risk death if infected emergence multidrug-resistant pneumococci. Infants young children, among whom incidence is high, respond poorly bacterial polysaccharides but develop satisfactory responses when these are linked chemically protein. early results trials such protein conjugate give promise significant portion paediatric will soon be feasible.

参考文章(51)
Austrian R, The Jeremiah Metzger Lecture: Of gold and pneumococci: a history of pneumococcal vaccines in South Africa. Transactions of the American Clinical and Climatological Association. ,vol. 89, pp. 141- 161 ,(1978)
Roderick Heffron, Pneumonia, with special reference to pneumococcus lobar pneumonia Harvard University Press. ,(1979)
John A. V. Davies, The Response of Infants to Inoculation with Type I Pneumococcus Carbohydrate Journal of Immunology. ,vol. 33, pp. 1- 7 ,(1937)
Michael Heidelberger, Marie M. Dilapi, Annabel W. Walter, Morris Siegel, Persistence of Antibodies in Human Subjects Injected with Pneumococcal Polysaccharides Journal of Immunology. ,vol. 65, pp. 535- 541 ,(1950)
Fred Neufeld, Ueber die Agglutination der Pneumokokken und über die Theorieen der Agglutination Medical Microbiology and Immunology. ,vol. 40, pp. 54- 72 ,(1902) , 10.1007/BF02140530
GAIL BOLAN, CLAIRE V BROOME, RICHARD R FACKLAM, BRIAN D PLIKAYTIS, DAVID W FRASER, WALTER F SCHLECH III, Pneumococcal Vaccine Efficacy in Selected Populations in the United States Annals of Internal Medicine. ,vol. 104, pp. 1- 6 ,(1986) , 10.7326/0003-4819-104-1-1
Colin M. MacLeod, Richard G. Hodges, Michael Heidelberger, William G. Bernhard, PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES Journal of Experimental Medicine. ,vol. 82, pp. 445- 465 ,(1945) , 10.1084/JEM.82.6.445
M. R. Reichler, A. A. Allphin, R. F. Breiman, J. R. Schreiber, J. E. Arnold, L. K. McDougal, R. R. Facklam, B. Boxerbaum, D. May, R. O. Walton, M. R. Jacobs, The Spread of Multiply Resistant Streptococcus pneumoniae at a Day Care Center in Ohio The Journal of Infectious Diseases. ,vol. 166, pp. 1346- 1353 ,(1992) , 10.1093/INFDIS/166.6.1346
Oscar Schiemann, Weitere Untersuchungen mit dem Kohlehydrat aus Typ-II-Pneumokokken Medical Microbiology and Immunology. ,vol. 110, pp. 567- 580 ,(1929) , 10.1007/BF02183231
Maxwell Finland, W. D. Sutliff, SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA : I. CASES RECEIVING NO SERUM THERAPY. Journal of Experimental Medicine. ,vol. 54, pp. 637- 652 ,(1931) , 10.1084/JEM.54.5.637